Article
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes
2023-01-27
Abstract excerpt
Molnupiravir, an antiviral medication that has been widely used against SARS-CoV-2, acts by inducing mutations in the virus genome during replication. Most random mutations are likely to be deleterious to the virus, and many will be lethal, and so molnupiravir-induced elevated mutation rates reduce viral load 2,3 . However, if some patients treated with molnupiravir do not fully clear SARS-CoV-2 infections, there...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 18df586e-ed7e-595a-98a6-c6efadec929b
- DOI
- 10.1101/2023.01.26.23284998
